Stock Taper
IMDX
INSIGHT MOLECULAR DIAGNOSTICS INC.
NASDAQ
$4.13
▼ DOWN 3.73% (-0.16)

KEY STATISTICS

Market Cap$133.36 M
52w High$8.51
52w Low$2.40
Dividend Yield
Frequency
P/E-2.77
Volume81.03K
Shares Out.32.29M

COMPANY

LEADERSHIP

Joshua Riggs
CHIEF EXECUTIVE
Joshua Riggs

COMPENSATION 2026

Salary$385,018
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$24,950
Total$786,077

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 30, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
57

PRICE TARGET

Target High$12.00
Target Low$8.00
Target Median$9.50
Target Consensus$9.75

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$215.12K
NOV
9
MON

SPLIT RECORD

DATETYPERATIO
2023-07-25Reverse1:20

PRICE

$4.13 ▼ DOWN 3.73% (−$0.16)
OVERLAYS
$4.13$4.20$4.289:36 AM10:40 AM11:44 AM12:47 PM1:51 PM2:55 PM3:59 PM4.13

About Insight Molecular Diagnostics Inc.

https://imdxinc.com ↗

OncoCyte Corporation, founded in 2009 in Irvine, CA, develops and commercializes proprietary molecular tests for cancer detection, including DetermaRx and DetermaIO, and collaborates with Life Technologies on advanced genomic assays.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT INSIGHT MOLECULAR DIAGNOSTICS INC. IS KNOWN FOR

GraftAssureCore
GraftAssureCore

GraftAssureCore is a CLIA-certified blood test that measures donor-derived cell-free DNA to monitor solid organ transplant rejection, with Medicare reimbursement and a target market of approximately $1 billion.

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q4-2025Q1-2026
Pharma Services$2.14M
Laboratory Services$494K $3.54M $32K

Revenue by Geography

MapREGIONQ1-2025Q2-2025Q4-2025Q1-2026
UNITED STATES$2.14M $494K $1.4M $32K
Europe$24K $0

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR
Arno Andrew
Sale · 12.1K shares
2026-07-01
DIRECTOR
SILVERMAN LOU
Sale · 7.7K shares
2026-07-01
DIRECTOR
Last Andrew J.
Sale · 7.7K shares
2026-07-01
DIRECTOR
Arno Andrew
Purchase · 32.3K shares
2026-06-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
OABI$4.47COMPARE
PRLD$5.47COMPARE
CCCC$3.85COMPARE
IVVD$0.96COMPARE
PEPG$3.08COMPARE
CDXS$1.59COMPARE
MIST$1.16COMPARE